Genome-wide association study for circulating tissue plasminogen activator levels and functional follow-up implicates endothelial STXBP5 and STX2.
Genome-wide association study for circulating tissue plasminogen activator levels and functional follow-up implicates endothelial STXBP5 and STX2.
复制标题
DOI:
10.1161/atvbaha.113.302088
复制
发表时间:
2014-05
期刊:
影响因子:
--
通讯作者:
CHARGE Consortium Hemostatic Factor Working Group
中科院分区:
文献类型:
--
作者:
Huang J;Huffman JE;Yamakuchi M;Trompet S;Asselbergs FW;Sabater-Lleal M;Trégouët DA;Chen WM;Smith NL;Kleber ME;Shin SY;Becker DM;Tang W;Dehghan A;Johnson AD;Truong V;Folkersen L;Yang Q;Oudot-Mellkah T;Buckley BM;Moore JH;Williams FM;Campbell H;Silbernagel G;Vitart V;Rudan I;Tofler GH;Navis GJ;Destefano A;Wright AF;Chen MH;de Craen AJ;Worrall BB;Rudnicka AR;Rumley A;Bookman EB;Psaty BM;Chen F;Keene KL;Franco OH;Böhm BO;Uitterlinden AG;Carter AM;Jukema JW;Sattar N;Bis JC;Ikram MA;Cohorts for Heart and Aging Research in Genome Epidemiology (CHARGE) Consortium Neurology Working Group;Sale MM;McKnight B;Fornage M;Ford I;Taylor K;Slagboom PE;McArdle WL;Hsu FC;Franco-Cereceda A;Goodall AH;Yanek LR;Furie KL;Cushman M;Hofman A;Witteman JC;Folsom AR;Basu S;Matijevic N;van Gilst WH;Wilson JF;Westendorp RG;Kathiresan S;Reilly MP;CARDIoGRAM Consortium;Tracy RP;Polasek O;Winkelmann BR;Grant PJ;Hillege HL;Cambien F;Stott DJ;Lowe GD;Spector TD;Meigs JB;Marz W;Eriksson P;Becker LC;Morange PE;Soranzo N;Williams SM;Hayward C;van der Harst P;Hamsten A;Lowenstein CJ;Strachan DP;O'Donnell CJ;CHARGE Consortium Hemostatic Factor Working Group
Tissue plasminogen activator (tPA), a serine protease, catalyzes the conversion of plasminogen to plasmin, the major enzyme responsible for endogenous fibrinolysis. In some populations, elevated plasma levels of tPA have been associated with myocardial infarction and other cardiovascular diseases (CVD). We conducted a meta-analysis of genome-wide association studies (GWAS) to identify novel correlates of circulating levels of tPA. Fourteen cohort studies with tPA measures (N=26,929) contributed to the meta-analysis. Three loci were significantly associated with circulating tPA levels (P <5.0×10−8). The first locus is on 6q24.3, with the lead SNP (rs9399599, P=2.9×10−14) within STXBP5. The second locus is on 8p11.21. The lead SNP (rs3136739, P=1.3×10−9) is intronic to POLB and less than 200kb away from the tPA encoding gene PLAT. We identified a non-synonymous SNP (rs2020921) in modest LD with rs3136739 (r2 = 0.50) within exon 5 of PLAT (P=2.0×10−8). The third locus is on 12q24.33, with the lead SNP (rs7301826, P=1.0×10−9) within intron 7 of STX2. We further found evidence for association of lead SNPs in STXBP5 and STX2 with expression levels of the respective transcripts. In in vitro cell studies, silencing STXBP5 decreased release of tPA from vascular endothelial cells, while silencing of STX2 increased tPA release. Through an in-silico lookup, we found no associations of the three lead SNPs with coronary artery disease or stroke. We identified three loci associated with circulating tPA levels, the PLAT region, STXBP5 and STX2. Our functional studies implicate a novel role for STXBP5 and STX2 in regulating tPA release.